Auth bypass in Apollo Pharmacy Blood Glucose Monitoring System (Model No. Apg-01 Bt)
CVE-2026-52866
- CVSS v3
- 6.5 Medium
- Public exploits
- None known
- EPSS
- 0.003 · 28.8th percentile
- Published
- 2026-06-19
An attacker within BLE communication range can monopolize the device's
only available BLE connection slot, preventing legitimate users or
applications from establishing a connection.
Vulnerability class: Broken Access Control
Published · last modified .
CVSS v3 metric
CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H.
- Attack Vector
- Adjacent
AV:A - Attack Complexity
- Low
AC:L - Privileges Required
- None
PR:N - User Interaction
- None
UI:N - Scope
- Unchanged
S:U - Confidentiality
- None
C:N - Integrity
- None
I:N - Availability
- High
A:H
EPSS exploit prediction
EPSS 0.003, 28.8th percentile (last changed ); unchanged over 30 days. About EPSS.
Affected products
- Apollo Pharmacy Blood Glucose Monitoring System (Model No. Apg-01 Bt) — versions 0x0110_v1.1.0